The FDA today floated some ideas on how it might regulate medical devices armed with artificial intelligence - also known as software-as-a-medical-device (SaMD) - whose algorithms can change based on machine learning (ML) and possibly affect people in ways for which they were not approved or cleared.
What I appreciate the most about genae is the consistent level of quality they produce. Our medical device study team is knowledgeable, capable and experienced; flexible with our changing needs, and very responsive to our concerns.
— Sara Vidmar, Vice President Clinical & Regulatory Affairs, Mitralign Inc., USA
Want to hear more about our services or how we can support your project? Feel free to contact us with any questions you may have.Contact us